Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04622579
What this trial is testing

Lenalidomide Combined With Rituximab as Front-line Therapy for DLBCL Patients Aged Over 80 Years

Who this might be right for
Diffuse Large B Cell LymphomaAge Over 80 Years
Guangdong Provincial People's Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT04262869
What this trial is testing

Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8+2 more
Emory University
Not applicableUnknownNCT04208854
What this trial is testing

Observational Study With Metronomic Oral Vinorelbine in Elderly Patients With Locally Advanced / Metastatic Non-small-cell Lung Cancer (NSCLC)

Who this might be right for
Locally Advanced/ Metastatic NSCLC
International Group of Endovascular Oncology 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07398560
What this trial is testing

Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

Who this might be right for
Small Cell Lung Cancer
The Third Affiliated Hospital of Harbin Medical University 47
Large-scale testing (Phase 3)Study completedNCT04992260
What this trial is testing

Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 11,349
Large-scale testing (Phase 3)Study completedNCT00278408
What this trial is testing

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 700
Large-scale testing (Phase 3)Study completedNCT00976456
What this trial is testing

Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
PD Dr. med. Wolfgang Schuette 271
Testing effectiveness (Phase 2)Looking for participantsNCT06835530
What this trial is testing

A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)

Who this might be right for
Diffuse Large B Cell Non-Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 47
Large-scale testing (Phase 3)Not Yet RecruitingNCT06654700
What this trial is testing

Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).

Who this might be right for
Herpes Zoster
MAXVAX Biotechnology Limited Liability Company 1,200
Testing effectiveness (Phase 2)Study completedNCT00256711
What this trial is testing

Phase II Iressa Versus Vinorelbine (INVITE)

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca 192
Post-approval studies (Phase 4)Looking for participantsNCT06646471
What this trial is testing

PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies

Who this might be right for
Non Small Cell Lung CancerLung Cancer
GFPC Investigation 500
Testing effectiveness (Phase 2)Study completedNCT00600977
What this trial is testing

Liposomal Anthracyclin in the Treatment of Elderly ALL

Who this might be right for
Acute Lymphoblastic Leukemia
French Innovative Leukemia Organisation 60
Testing effectiveness (Phase 2)Study completedNCT04869592
What this trial is testing

A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19

Who this might be right for
COVID-19
National Vaccine and Serum Institute, China 3,100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05004064
What this trial is testing

Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
University College, London 48
Large-scale testing (Phase 3)Study completedNCT01774032
What this trial is testing

H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older

Who this might be right for
Influenza
Alachua Government Services, Inc. 91
Not applicableActive Not RecruitingNCT03035604
What this trial is testing

Comprehensive Nutritional Geriatric Assessments in Identifying Malnutrition in Older Cancer Participants

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 180
Large-scale testing (Phase 3)Not Yet RecruitingNCT07728955
What this trial is testing

A Single-arm, Exploratory Clinical Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Anlotinib and Etoposide as First-line Therapy for Elderly Patients With Small-cell Lung Cancer or Those Who Are Intolerant to Intensive Chemotherapy

Who this might be right for
Small Cell Lung Cancer ( SCLC )
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 64
Early research (Phase 1)Active Not RecruitingNCT06335849
What this trial is testing

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years

Who this might be right for
Herpes Zoster
Guangzhou Patronus Biotech Co., Ltd. 48
Large-scale testing (Phase 3)Study completedNCT04510207
What this trial is testing

Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above

Who this might be right for
COVID-19
China National Biotec Group Company Limited 44,101
Testing effectiveness (Phase 2)UnknownNCT04990544
What this trial is testing

Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

Who this might be right for
COVID-19
Shanghai Zerun Biotechnology Co.,Ltd 528
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation